NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT01806675 2019-10-0318F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyStanford UniversityPhase 1/2 Completed25 enrolled 14 charts
NCT02042885 2015-10-20A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerOtsuka Novel Products GmbHPhase 1/2 Terminated79 enrolled
NCT00101348 2014-06-11Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Completed66 enrolled